कोशिश गोल्ड - मुक्त
CELEBRATING WOMANHOOD ON EQUAL NOTE
BioSpectrum Asia
|March 2020
As nations around the world celebrate International Women’s Day on March 8, with the theme #EachforEqual, the number of companies that have had women in a leadership role continues to expand. But the list is still relatively short, and even when women have made it to power, they have rarely led for a long time. Globally women at leadership position are very less and only 4.9 per cent of Fortune 500 companies have women at leadership position.

Women are still vastly underrepresented in the science fields, even today. There’s a lack of diverse perspectives and voices creating the next life-changing technologies in our societies – a huge missed opportunity. “There are probably many reasons for this. Part of it could be social pressures, but we think a big reason for this is a lack of role models for the young to follow,” says Dr. Low Yen Ling, Divisional Vice President of Scientific & Medical Affairs, Abbott.
At Abbott, Dr. Low Yen Ling adds “advancing the role of women is important to our business and to the organizations and communities we work with around the world. We value diversity and there are initiatives in place such as Abbott’s Women Leaders in Action (WLA) whose mission is to develop women to excel in the organization and support them to increasing levels of leadership.”
In the Clinical Research Organisation (CRO) industry, women tend to dominate entry-level positions, but numbers decline at more senior and executive levels. Family obligations are practical hurdles for women and often take priority over a professional career – indeed culturally in Asia women take on more family responsibilities than men. In addition, often it’s not easy to successfully transition back to work.
Dr. Yooni Kim, Executive Director, Asia Operations, Novotech, Seoul, South Korea says “I think it’s improving. More healthcare companies are focusing on how they can support women and keeping them with the company. Flexible work arrangements is one solution that help women employees manage their lives.” Novotech encourages its people to engage in flexible working practices across all its Asia locations. Both men and women benefit from this, and Novotech’s supportive parental leave program.
यह कहानी BioSpectrum Asia के March 2020 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 9,500 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
BioSpectrum Asia से और कहानियाँ

BioSpectrum Asia
Collaborative R&D: Partnerships shaping the future of biopharma
Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.
2 mins
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Quantum Computing: Future of diagnostics is being coded today
A silent revolution is being built at the intersection of biology and quantum physics. After decades of pushing the boundaries of diagnostics with advanced imaging and AI, we are now approaching a hard computational wall. For complex conditions like Alzheimer's, Parkinson's, and many cancers, the interacting variables of genomics, proteomics, and real-world patient data are simply too vast for classical computers to master. This limitation caps the ability to move from merely spotting correlations to uncovering true causation. Unlike traditional AI, quantum computing can simulate underlying physical systems to derive precise solutions. The transition from correlational analysis to causal simulation will enable a more valuable and advanced frontier in diagnostics.
4 mins
BioSpectrum Asia Sep 2025
BioSpectrum Asia
First Pacific woman to serve as public health director in NZ
The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Hugel launches botulinum toxin Letybo in Malaysia
South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Australia designs smart wound monitor to improve chronic infection care
Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Revvity unveils innovative reagent technology to accelerate therapeutics development
US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B
Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education
HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI
Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.
1 min
BioSpectrum Asia Sep 2025
Translate
Change font size